Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Caboxamycin with Antiviral Activity in CVB3-Induced Myocarditis Mouse Model

Version 1 : Received: 29 September 2023 / Approved: 29 September 2023 / Online: 29 September 2023 (15:42:05 CEST)

How to cite: Kim, H.; Hillman, P.F.; Lee, Y.; Jeon, H.; Lim, B.; Nam, S. Caboxamycin with Antiviral Activity in CVB3-Induced Myocarditis Mouse Model. Preprints 2023, 2023092120. https://doi.org/10.20944/preprints202309.2120.v1 Kim, H.; Hillman, P.F.; Lee, Y.; Jeon, H.; Lim, B.; Nam, S. Caboxamycin with Antiviral Activity in CVB3-Induced Myocarditis Mouse Model. Preprints 2023, 2023092120. https://doi.org/10.20944/preprints202309.2120.v1

Abstract

Coxsackievirus B3 (CVB3) is one of the most common pathogens that cause myocarditis in humans. However, a sufficient therapeutic drug was not developed yet. Caboxamycin, a benzoxazole antibiotic, isolated from the culture broth of the marine strain Streptomyces sp., SC0774, displayed an antiviral effect in the CVB3-infected HeLa cells and CVB3-induced myocarditis mouse model. Caboxamycin significantly inhibited CVB3 VP1 production and cleavage of translation factor eIF4G1 from CVB3-infected HeLa cells at a 100 μg/ml concentration. Moreover, virus RNA amplification was dramatically reduced by caboxamycin treatment in HeLa cells. The caboxamycin cardiac protective effect was observed on the CVB3-mediated myocarditis mice model. The caboxamycin-treated mice survival was significantly increased compared to untreated mice (treated vs untreated, 100 vs 45 %). Heart histologic findings showed that myocardium damage and inflammation were significantly decreased by caboxamycin treatment. Caboxamycin directly inhibited caspase3 activity and cardiac myocytes apoptosis. These results suggested that caboxamycin strongly suppressed cardiac myocyte apoptosis and effectively inhibited the proliferation of CVB3 from in vitro and in vivo conditions. Furthermore, this study proposed that caboxamycin could potentially be applied in developing a new antiviral drug for CVB3-induced myocarditis.

Keywords

coxsackievirus B3; myocarditis; apoptosis; caboxamycin; Streptomyces sp. SC0774

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.